470512, doi:10.1124/pr.108.000604, PMID 19074620, PMC 2696340 (freier Volltext) (englisch)
Providers often reduce semaglutide dose during prednisone taper or instruct patients to monitor for symptoms like tremor, sweating, and confusion
At the individual animal level, gut fill and rumen microbial activity can also have an effect
Semaglutide is a once-weekly self-administered injection used to treat general weight loss, obesity, and even diabetes
Slowing the rate of weight loss and maintaining proper nutrition, especially sufficient protein intake, can help reduce these effects
Atomoxetine, a norepinephrine reuptake inhibitor, does not compete with GLP-1 receptor activity, making it a generally safe choice for patients using semaglutide